About Lucid Psycheceuticals
Lucid Psycheceuticals is a company based in Toronto (Canada) founded in 2020 by Joseph L Romano was acquired by FSD Pharma in September 2021. The company has 5 employees as of December 31, 2024.
- Headquarter Toronto, Canada
- Employees 5 as on 31 Dec, 2024
- Founders Joseph L Romano
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
5
as on Dec 31, 2024
-
Acquired by
FSD Pharma
(Sep 21, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Lucid Psycheceuticals
Detailed funding history for Lucid Psycheceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Lucid Psycheceuticals
Lucid Psycheceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include FSD Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cannabis company engaged in cultivation, processing, and manufacturing related activities
|
Locked | Locked | Locked |
Investor details for Lucid Psycheceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lucid Psycheceuticals
Investment portfolio details for Lucid Psycheceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lucid Psycheceuticals
Detailed financials for Lucid Psycheceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lucid Psycheceuticals Comparisons
Peer comparison for Lucid Psycheceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lucid Psycheceuticals
Detailed competitors of Lucid Psycheceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lucid Psycheceuticals
Complete news archive for Lucid Psycheceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lucid Psycheceuticals
Lucid Psycheceuticals was founded in 2020.
Lucid Psycheceuticals is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
As of Dec 31, 2024, the latest employee count at Lucid Psycheceuticals is 5.
Lucid Psycheceuticals was founded in 2020 in Toronto, Canada, within the pharmaceutical sector. Focus is placed on the production of drugs aimed at treating various mental health disorders. Operations are centered on research, development, and manufacturing processes to address these conditions. Leadership includes co-founder Joseph L. Romano, with activities conducted primarily from the Canadian base to serve related healthcare needs.
Lucid Psycheceuticals has 1 investor. Key investors include FSD Pharma.